SEC Filing Details

Document Details

Form
3
Filing Date
Aug 17, 2023
Document Date
Aug 14, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
Douglas Earl Martin